Cargando…

STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN

Release of the protein molecule, leukocytic pyrogen, is one of the many reactions exhibited by leukocytes after phagocytosis. After the ingestion of heat-killed S. albus, a 3–4 hr latent period exists, during which human peripheral leukocytes release no pyrogen, yet cellular metabolism is altered in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordlund, James J., Root, Richard K., Wolff, Sheldon M.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1970
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138772/
https://www.ncbi.nlm.nih.gov/pubmed/5430786
_version_ 1782143641003753472
author Nordlund, James J.
Root, Richard K.
Wolff, Sheldon M.
author_facet Nordlund, James J.
Root, Richard K.
Wolff, Sheldon M.
author_sort Nordlund, James J.
collection PubMed
description Release of the protein molecule, leukocytic pyrogen, is one of the many reactions exhibited by leukocytes after phagocytosis. After the ingestion of heat-killed S. albus, a 3–4 hr latent period exists, during which human peripheral leukocytes release no pyrogen, yet cellular metabolism is altered in such a way that pyrogen output may subsequently occur in the absence of further phagocytosis. Transcription of messenger RNA and translation of new protein are initial events in the. activation process, since addition of the inhibitors, actinomycin D, and cycloheximide or puromycin, during this period markedly depressed or abolished subsequent pyrogen release. These effects were noted to be dependent upon the time of addition of the inhibitors. None of the inhibitor drugs interfered with cell viability as measured by phagocytosis and hexose monophosphate shunt activity, nor did they alter the pyrogenicity of preformed leukocytic pyrogen. Vincristine did not inhibit pyrogen formation, consistent with its reported failure to alter RNA synthesis in mature human granulocytes. The glycolytic inhibitor, sodium fluoride, blocked pyrogen release both when added prior to particle ingestion or 1 hr after the initiation of phagocytosis. Whereas inhibition of phagocytosis would explain the sodium fluoride effect prior to 1 hr, this was not observed in leukocyte preparations incubated for 1 hr with S. albus before adding sodium fluoride. When sodium fluoride was added to preparations 2 hr after the start of incubation, the LP production was unimpaired. Potassium cyanide had no effect on cell activation or pyrogen release. These findings suggest that the primary energy supply for the activation process is derived from high energy phosphate bonds provided by anaerobic glycolysis. Since the major amount of cell activation appears to occur in the 1st hr after phagocytosis, this energy might be involved in the induction of a genome leading to the transcription of m-RNA and its translation into new protein or is required for polysome integrity during protein synthesis. It is suggested that this new protein may be leukocytic pyrogen itself, or an enzyme responsible for cleaving it from an inactive precursor.
format Text
id pubmed-2138772
institution National Center for Biotechnology Information
language English
publishDate 1970
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21387722008-04-17 STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN Nordlund, James J. Root, Richard K. Wolff, Sheldon M. J Exp Med Article Release of the protein molecule, leukocytic pyrogen, is one of the many reactions exhibited by leukocytes after phagocytosis. After the ingestion of heat-killed S. albus, a 3–4 hr latent period exists, during which human peripheral leukocytes release no pyrogen, yet cellular metabolism is altered in such a way that pyrogen output may subsequently occur in the absence of further phagocytosis. Transcription of messenger RNA and translation of new protein are initial events in the. activation process, since addition of the inhibitors, actinomycin D, and cycloheximide or puromycin, during this period markedly depressed or abolished subsequent pyrogen release. These effects were noted to be dependent upon the time of addition of the inhibitors. None of the inhibitor drugs interfered with cell viability as measured by phagocytosis and hexose monophosphate shunt activity, nor did they alter the pyrogenicity of preformed leukocytic pyrogen. Vincristine did not inhibit pyrogen formation, consistent with its reported failure to alter RNA synthesis in mature human granulocytes. The glycolytic inhibitor, sodium fluoride, blocked pyrogen release both when added prior to particle ingestion or 1 hr after the initiation of phagocytosis. Whereas inhibition of phagocytosis would explain the sodium fluoride effect prior to 1 hr, this was not observed in leukocyte preparations incubated for 1 hr with S. albus before adding sodium fluoride. When sodium fluoride was added to preparations 2 hr after the start of incubation, the LP production was unimpaired. Potassium cyanide had no effect on cell activation or pyrogen release. These findings suggest that the primary energy supply for the activation process is derived from high energy phosphate bonds provided by anaerobic glycolysis. Since the major amount of cell activation appears to occur in the 1st hr after phagocytosis, this energy might be involved in the induction of a genome leading to the transcription of m-RNA and its translation into new protein or is required for polysome integrity during protein synthesis. It is suggested that this new protein may be leukocytic pyrogen itself, or an enzyme responsible for cleaving it from an inactive precursor. The Rockefeller University Press 1970-03-31 /pmc/articles/PMC2138772/ /pubmed/5430786 Text en Copyright © 1970 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Nordlund, James J.
Root, Richard K.
Wolff, Sheldon M.
STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN
title STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN
title_full STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN
title_fullStr STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN
title_full_unstemmed STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN
title_short STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN
title_sort studies on the origin of human leukocytic pyrogen
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138772/
https://www.ncbi.nlm.nih.gov/pubmed/5430786
work_keys_str_mv AT nordlundjamesj studiesontheoriginofhumanleukocyticpyrogen
AT rootrichardk studiesontheoriginofhumanleukocyticpyrogen
AT wolffsheldonm studiesontheoriginofhumanleukocyticpyrogen